Furthermore, administration of the proteasome inhibitor MG132 restored ARF levels in SIRT7-depleted H1299 lung cancer cells transfected with WT and catalytic inactive mutant SIRT7 (Fig. 2C). Here, CDKN2A is linked to lung cancer.